Transcatheter or surgical aortic valve implantation in chronic dialysis patients: a German Aortic Valve Registry analysis
Autor: | Eva Herrmann, Thomas Walther, Wolfgang Harringer, Christian W. Hamm, Friedhelm Beyersdorf, Sabine Bleiziffer, Dimitra Bon, Christian Frerker, Hugo A. Katus, Andreas Beckmann, Helge Möllmann, Stephan Ensminger, Andreas Böning, Raffi Bekeredjian, Helge Weiler, G. Färber, Stephan Fichtlscherer, Torsten Doenst, Timm Bauer |
---|---|
Rok vydání: | 2020 |
Předmět: |
Male
Aortic valve medicine.medical_specialty Time Factors medicine.medical_treatment Comorbidity 030204 cardiovascular system & hematology Transcatheter Aortic Valve Replacement 03 medical and health sciences 0302 clinical medicine Aortic valve replacement Renal Dialysis Risk Factors Germany Internal medicine Humans Medicine Prospective Studies Registries 030212 general & internal medicine Risk factor Propensity Score Dialysis Aged business.industry Atrial fibrillation EuroSCORE Aortic Valve Stenosis General Medicine medicine.disease Treatment Outcome medicine.anatomical_structure Aortic Valve Heart Valve Prosthesis Aortic valve stenosis Conventional PCI Cardiology Kidney Failure Chronic Female Cardiology and Cardiovascular Medicine business Follow-Up Studies |
Zdroj: | Clinical Research in Cardiology. 110:357-367 |
ISSN: | 1861-0692 1861-0684 |
Popis: | The aim of this study was to compare outcomes of transcatheter and surgical aortic valve implantation in chronic dialysis patients with aortic valve stenosis (AS). Chronic dialysis patients undergoing heart valve surgery are at higher risk for morbidity and mortality. Whether interventional techniques can reduce this risk is unclear because dialysis patients have thus far been excluded from randomized trials. Chronic dialysis patients with AS enrolled in the German Aortic Valve Registry (GARY) between 2012 and 2015 were analyzed to compare transcatheter aortic valve implantation (TAVI n = 661) with surgical aortic valve replacement (SAVR n = 457). Propensity scores for inverse probability of treatment weighting (IPTW) were used to adjust the comparison of the two treatment groups for potential confounders. TAVI patients were older (78 ± 7.3 vs. 69 ± 10.2 years, p |
Databáze: | OpenAIRE |
Externí odkaz: |